BTIG downgraded Endologix (NASDAQ: ELGX) from Buy to Neutral. Analyst Sean Lavin expects investor turnover.

"While guidance will hit ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE